Clinical Testing News and Research

RSS

Revisions to ISO 80396 for Luer Lock Testing Require Reliable Testing Solution to Ensure Data Integrity

New series of ISO 80369 standards for Luer lock testing are pending release, meaning the medical industry will have to redesign small-bore tubing connectors.

2 Oct 2020

Computer-designed proteins protect lab-grown human cells from SARS-CoV-2

Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19.

10 Sep 2020

Drug-like compounds previously developed to fight SARS may also work against COVID-19

An extensive search and testing of current drugs and drug-like compounds have revealed compounds previously developed to fight SARS might also work against COVID-19.

28 Aug 2020

Machines match expert human assessment of stored red blood cell quality

Each year, nearly 120 million units* of donated blood flow from donor veins into storage bags at collection centres around the world.

25 Aug 2020

Microsoft's AI supports the development of Vaxine's COVAX-19 vaccine

Given the global urgency of the COVID-19 pandemic, Microsoft's AI for Health program has stepped in to support the development and potential deployment of Vaxine's COVAX-19™ vaccine with a philanthropic grant.

25 Aug 2020

Programmable DNA nanoswitches can rapidly detect emerging viruses, including SARS-CoV-2

Programmable DNA nanoswitches that bind to viral RNA in human body fluids may provide an inexpensive platform to rapidly detect a wide variety of emerging viruses, including SARS-CoV-2, according to a new study.

24 Aug 2020

Researchers estimate the cost-effectiveness and health impact of BRCA testing

Screening entire populations for breast and ovarian cancer gene mutations could prevent millions more breast and ovarian cancer cases across the world compared to current clinical practice, according to an international study led by Queen Mary University of London.

20 Jul 2020

NIH establishes clinical trial network to test vaccines and monoclonal antibodies for COVID-19

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has established a new clinical trial network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.

14 Jul 2020

New cell therapy proves effective in human and mouse tumor models

A new study published recently in eLife reports that researchers have developed new immunotherapy that eliminates solid tumors in mice without causing detrimental side effects.

1 Apr 2020